Immunohistochemical profiling is essential for differentiating PASH from low-grade angiosarcoma, with specific markers such as CD34, vimentin, desmin, actin, and progesterone receptor aiding in the correct diagnosis and preventing misinterpretation. This evidence concerns the gene CD34 and Pyoderma gangrenosum-acne-suppurative hidradenitis syndrome.